A phase II clinical trial of chidamide in combination with toripalimab in patients with advanced soft tissue sarcoma

被引：0
|
作者：
Zhang, Xing
Peng, Ruiqing
Pan, Qiuzhong
Xu, Bushu
Hong, Dongchun
Que, Yi
机构：
[1] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, Ctr Canc, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11566
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
    Hartmann, JT
    Oechsle, K
    Mayer, F
    Kanz, L
    Bokemeyer, C
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1899 - 1901
  • [22] Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
    Späth-Schwalbe, E
    Genvresse, I
    Koschuth, A
    Dietzmann, A
    Grunewald, R
    Possinger, K
    ANTI-CANCER DRUGS, 2000, 11 (05) : 325 - 329
  • [23] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
  • [24] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    Losa, R.
    Fra, J.
    Lopez-Pousa, A.
    Sierra, M.
    Goitia, A.
    Una, E.
    Nadal, R.
    del Muro, J. Garcia
    Gion, M.
    Maurel, J.
    Escudero, P.
    Esteban, E.
    Buesa, Jose M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) : 251 - 259
  • [25] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    R. Losa
    J. Fra
    A. López-Pousa
    M. Sierra
    A. Goitia
    E. Uña
    R. Nadal
    J. García del Muro
    M. Gión
    J. Maurel
    P. Escudero
    E. Esteban
    José M. Buesa
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 251 - 259
  • [26] A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).
    Wilky, Breelyn A.
    Trucco, Matteo Maria
    Kolonias, Despina
    Wieder, Eric
    Subhawong, Ty
    Rosenberg, Andrew
    Kwon, Deukwoo
    Park, Wungki
    Florou, Vaia
    Kerr, Darcy A.
    Sfakianaki, Efrosyni
    Merchan, Jaime R.
    Komanduri, Krishna
    Trent, Jonathan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] PHASE-II TRIAL OF CARBOPLATIN IN SOFT-TISSUE SARCOMA
    GOLDSTEIN, D
    CHEUVART, B
    TRUMP, DL
    SHIRAKI, M
    COMIS, RL
    TORMEY, DC
    HARRIS, JE
    BORDEN, EC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 420 - 423
  • [28] Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).
    Naito, Yoichi
    Kawai, Akira
    Araki, Nobuhito
    Ozaki, Toshifumi
    Sugiura, Hideshi
    Yazawa, Yasuo
    Morioka, Hideo
    Matsumine, Akihiko
    Hiraiwa, Masahide
    Asami, Shun
    Isu, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] ORAL PIRITREXIM - A PHASE-II STUDY IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    SCHIESEL, JD
    CARABASI, M
    MAGILL, G
    CASPER, E
    CHENG, E
    MARKS, L
    FEYZI, J
    CLENDENINN, NJ
    SMALLEY, RV
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) : 97 - 98
  • [30] Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients
    Yovine, A
    Riofrio, M
    Blay, JY
    Brain, E
    Alexandre, J
    Kahatt, C
    Taamma, A
    Jimeno, J
    Martin, C
    Salhi, Y
    Cvitkovic, E
    Misset, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 890 - 899
12345